Category: Finance
Top 10 at 10: Uranium speccies on the rise as wilting lithium developer Liontown sinks below $1
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. [more…]
First Lithium’s drilling paints a pretty picture of Blakala’s lithium prospectivity
Diamond drilling continues to intersect high-grade lithium at Blakala High-grade mineralised strike now confirmed to a length of 960m Drilling is continuing with further assays [more…]
Market Highlights: S&P 500 climbs to record high, Big 4 banks’ earnings prediction, and 5 ASX small caps to watch
ASX to climb after S&P 500 hit record high Tesla and IBM are set to release their earnings this week And what Aussie big four [more…]
Confessions of a Day Trader: $2200 in a day? That’s gold, that is!
Each week, Stockhead’s resident day trader gives us a peek at the highs and lows of his trading diary and hints at what might be [more…]
Traders’ Diary: Everything you need to know before the ASX opens
What grabbed the headlines last week? Offshore, resilient economic data in the US was a key theme. Strong retail trade and low initial jobless [more…]
Hot Money Monday: Laramide, Andromeda, Cryosite are rising on momentum. Are they a buy?
The rationale behind momentum trading strategy is that, if there is enough buying force behind the rise in the price of a stock, the stock [more…]
TEN BAGGER: Why fundies are looking off the ASX for the next big thing
Welcome to Ten Bagger, where Lowell Resources Fund chief investment officer John Forwood gives us his take on a sector of the ASX resources market [more…]
Rise and Shine: Everything you need to know before the ASX opens-2414
Good morning everyone, and welcome to 20 January, 2024 – a date on the calendar that’s very important to the people of Finland, as it was [more…]
Explorers Podcast: Nordic Nickel packs its bags for a busy year of drilling
Stockhead’s ‘Garimpeiro’ columnist Barry FitzGerald is back in the studio for another instalment of The Explorers Podcast. In this episode Barry chats to Todd Ross, [more…]
Bioxyne subsidiary unveils platform for transparent pricing in Australia’s B2B medical cannabis market
Bioxyne subsidiary Breath Life Sciences launches CanxChange.com.au Offers transparency in pricing and supply in Australia’s B2B prescription cannabis industry Platform has seen more than [more…]
